Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Gu currently holds 25,000 shares of Cellectar Biosciences, Inc. (CLRB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Gu has been a net neutral trader of CLRB stock. They have purchased $0 and sold $0 worth of shares.
Andrew Gu's most recent insider trade was on Jul 7, 2026, when they sold 25,000 shares at $0.00 per share.
Andrew Gu serves as Executive at Cellectar Biosciences, Inc. (CLRB). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Andrew Gu holds the position of Executive at Cellectar Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Andrew Gu has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Andrew Gu was on Jul 7, 2026, when they purchased $0 worth of CLRB shares. This transaction involved 25,000 shares at N/A per share.
Andrew Gu currently owns 25,000 shares of Cellectar Biosciences, Inc. (CLRB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Gu's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Gu has 1 Form 4 filings on record as an insider at Cellectar Biosciences, Inc..
Set alerts for Andrew Gu and 40,000+ other insiders.